Research has uncovered that cortisone binding to glucocorticoid receptors (GR) in pancreatic cancer elicits tumor proliferation, metastasis, and gemcitabine resistance via diverse signaling cascades (63). The gene discussed is NR3C1; the disease is neoplasm.